Ralexar Investigational Site 35 — Anniston, Alabama

Ralexar Investigational Site 35 is a clinical research site located in Anniston, Alabama, United States 36207.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Ralexar Investigational Site 35 has participated in 1 clinical trials.

Therapeutic areas: Atopic Dermatitis, Eczema, Atopic.

Sponsors: Ralexar Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Anniston

Browse all research sites in Alabama · View every site in Anniston

• Pinnacle Research Group
• Northeast Alabama Regional Medical Center
• Research Site
• GSK Investigational Site
• Novartis Investigative Site
• Regional Medical Center
• Pfizer Investigational Site
• Novo Nordisk Investigational Site
• Local Institution
• Pinnacle Research Group; Llc, Central
• Investigational Site Number 840070
• Anniston Medical Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ralexar Investigational Site 35?

Ralexar Investigational Site 35 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ralexar Investigational Site 35 conducted?

Ralexar Investigational Site 35 has 1 clinical trials on record. Their work covers Atopic Dermatitis, Eczema, Atopic.

Is Ralexar Investigational Site 35 accredited by Crixeo Clinical Trials?

Ralexar Investigational Site 35 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ralexar Investigational Site 35?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.